President Trump's Nomination of Kevin Warsh as Fed Chair May Come Back to Bite Wall Street The stock market's biggest threat may be an upcoming shift at America's foremost financial institution.
Binance founder CZ Slams New York Times Over Leaked Draft Detailing $4.3B Settlement Talks The New York Times reported on a draft of Changpeng Zhao’s memoir, which the Binance founder publicly objected to.
Benzinga Bulls And Bears: Rocket Lab, Kosmos Energy, Novo Nordisk — And Nvidia Fails To Boost Markets Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Down 20% in February, Is Lemonade Stock a Buy Now? Lemonade is doing an excellent job of growth, and its latest results look great.
Here's the Average 401(k) Balance by Age vs. What You Actually Need Here's how the average 401(k) balance stacks up against what experts recommend -- broken down by generation, with tips to close the gap.
The Smartest Dividend Stocks to Buy With $150 Right Now These pipeline companies could deliver high-octane total returns in the coming years.
Should Long-Term Investors Steer Clear of Leveraged ETFs? Leverage works both ways, a fact you can't forget if you buy a leveraged ETF like UltraPro S&P 500 ETF.
Prediction: The AI Capex War Will Create a Clear Winner by the End of 2026 The race is on, and major tech players are spending big on data centers for their AI goals.
Got $5,000? 1 Tech Stock to Buy and Hold for the Long Term. Investing in Alphabet can set you up for more upside as the company continues to expand in multiple high-growth industries.
Struggling to Pick Artificial Intelligence (AI) Stocks? You're Not Alone -- Try This ETF Instead An exchange-traded fund can save investors from picking winners and losers in complex industries like artificial intelligence.
Can You Retire Comfortably on $1 Million in Savings? Many people can do quite well retiring with a million dollars -- but not everyone.
Analysts Are Calling ‘Jane Street 10 AM Bitcoin Dump’ Theory ‘Fake News’ Economist Alex Krüger pointed out that institutional trading involves buying Bitcoin and hedging with futures, arguing this does not amount to deliberate price suppression.
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade The U.S.-based biotech specializes in treating cancers with small molecules, antibody-drug conjugates, and other biotherapeutics.
Interactive Brokers' 2025 Recap: A Year of Scale, Discipline, and Momentum By scaling efficiently, strengthening client trust, and converting growth into clean profits, Interactive Brokers proved that disciplined execution can be more potent than flashy innovation.
